Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Customize your policy alerts
Sign up for healthplanofupperohiovalley Policy 21641356 alerts
Get alerted when Policy 21641356 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage of HIPEC, also called intraperitoneal hyperthermic chemotherapy, when performed with cytoreductive surgery for selected advanced abdominal and peritoneal malignancies. It applies to all lines of business and requires medical-necessity documentation and precertification support.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.